Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 9.53 CAD -1.35% Market Closed
Market Cap: 3.5B CAD

Bausch Health Companies Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Bausch Health Companies Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bausch Health Companies Inc
TSX:BHC
Revenue
$10B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
0%
Canopy Growth Corp
TSX:WEED
Revenue
CA$278.6m
CAGR 3-Years
-16%
CAGR 5-Years
-10%
CAGR 10-Years
52%
Sundial Growers Inc
NASDAQ:SNDL
Revenue
CA$951.6m
CAGR 3-Years
24%
CAGR 5-Years
73%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Revenue
$132.4m
CAGR 3-Years
12%
CAGR 5-Years
29%
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Revenue
CA$413.8m
CAGR 3-Years
15%
CAGR 5-Years
18%
CAGR 10-Years
87%
NervGen Pharma Corp
XTSX:NGEN
Revenue
CA$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bausch Health Companies Inc
Glance View

Bausch Health Companies Inc. stands as a prominent player in the global healthcare arena, with its roots stretching back over a century. Originally known as Valeant Pharmaceuticals, the firm has undergone significant transformation, focusing on a diverse array of health-related products and innovations. The company operates primarily in three segments: Bausch + Lomb/International, Salix, and Ortho Dermatologics. Each of these divisions articulates its commitment to enhancing patients' lives through high-quality products that address the complex challenges of eye care, gastroenterology, and dermatology, respectively. The Bausch + Lomb sector, named after its foundational company, is recognized globally for its wealth of eye health products, including contact lenses, lens care products, and ophthalmic pharmaceuticals. This sector is integral to Bausch Health's revenue stream, contributing significantly through its diverse portfolio of over-the-counter and prescription offerings. At its core, Bausch Health has honed a business model centered around acquiring and developing specialty pharmaceuticals and health-enhancing technologies. Through strategic acquisitions, partnerships, and internal research, the company curates a vast pipeline of treatments and solutions. Revenue generation for Bausch Health is intrinsically linked to its global market footprint, operating in more than 100 countries. Sales teams across these regions work diligently to ensure that healthcare professionals and consumers alike have access to their products. Meanwhile, the company's commitment to innovation helps it remain responsive in rapidly evolving medical fields. The sales and marketing strategies are finely tuned to address regional disparities, leveraging local insights to maximize market penetration and bolster growth. Ultimately, Bausch Health Companies Inc. thrives by bridging high-quality health solutions with unmet global needs, seeking to leave a lasting impact on the lives it touches.

BHC Intrinsic Value
HIDDEN
Show

See Also

What is Bausch Health Companies Inc's Revenue?
Revenue
10B USD

Based on the financial report for Sep 30, 2025, Bausch Health Companies Inc's Revenue amounts to 10B USD.

What is Bausch Health Companies Inc's Revenue growth rate?
Revenue CAGR 10Y
0%

Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Bausch Health Companies Inc have been 7% over the past three years , 5% over the past five years .

Back to Top